Pediatric Perfusion Market Size, Share and Global Trend By Product (Pediatric cannulae, Pediatric Centrifugal Blood Pumps, Pediatric Arterial Line Filters, Hemoconcentrators, HMS Plus Hemostasis Management System, Pediatric oxygenation systems), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Others), and Regional Forecast, 2024-2032

Perfusion is the method of the passage of blood through the lymphatic system or circulatory system to a tissue or an organ. Many children suffer from congenital heart disease and undergo heart surgeries that require pediatric perfusion devices. These devices are considered as supporting circulatory devices that are used in diverting the blood from the lungs and heart of the patient and to help in maintaining blood circulation during pediatric cardiac surgeries.

Children less than a year old usually undergo open heart surgeries due to heart defects that occurs during birth such as ventricular septal defect (VSP) for instance according to Centers Of Disease Control And Prevention (CDC), 16,800 babies in United States are born with ventricular septal defect and one million children suffers from congenital heart defects which has raised the demand of effective and non-invasive treatment methods to cure the heart defects and these factors are likely to fuel the growth in pediatric perfusion market during the projected period.

The growth of the global pediatric perfusion market is being driven by the increasing prevalence of congenital heart disease and growing awareness about the new treatment of various cardiac abnormalities. In addition, the growing demand for minimally invasive, effective technology and growing adoption of pediatric perfusion technology to treat congenital heart disease are anticipated to enhance the market of pediatric perfusion during the forecast period.

However, high cost associated with pediatric cardiac heart surgeries which is unaffordable by low-middle income countries is anticipated to hamper the growth in global pediatric perfusion market during the forecast period.

Key Players Covered

Some of the major companies that are present in the pediatric perfusion market include MEDIVATORS Inc., LivaNova PLC, Terumo Cardiovascular Systems Corporation., Medtronic, BL Lifesciences, Koninklijke Philips N.V., EUROSETS, General Electric Company, Terumo Medical Corporation, among others.

SEGMENTATION

Among product segmentation, pediatric cannulae is anticipated to hold the largest pediatric perfusion market share during the forecast period as they overcome the limitations of extracorporeal life support (ECLS) circuit by accommodating the largest diameter venous cannula and reduces the blood drainage via the venous cannula.

Key Insights

• Epidemiology Analysis of Congenital Heart Disease among children
• Overview of Advancement in Pediatric Perfusion Methods
• Pricing Analysis for key Products
• The Regulatory Scenario for Key Countries/Regions
• Key Mergers and Acquisitions

Regional Analysis

The global pediatric perfusion market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Due to the new product launches by many key players, growing prevalence of heart disease in children, and growing demand for effective technologies used during heart surgeries are likely to fuel the growth of the global pediatric perfusion system market in North America during the projected period. The market in the Asia Pacific region is anticipated to grow at a significant rate owing to the growing patient population and surge in the investments in research and development activities by many healthcare organizations.

Key Industry Developments

Medtronic developed Affinity Pixie a pediatric oxygenators or neonates, infants, and small children requiring cardiopulmonary bypass at flow rates up to 2.0 L/min